TKT R438W
T cell immunity directed against tumor-encoded amino acid substitutions occurs in some melanoma patients. This implicates missense mutations as a source of patient-specific neoantigens. TKT R438W is characterized as subdominant antigens as T cell immunity required peptide vaccination and these neoantigens are processed and presented from endogenously expressed protein.
-
- Epitope: AMFWSVPTV
- MHC: HLA-A*02:01
Compare
-
- Epitope: AMFWSVPTV
- MHC: HLA-A*02:01
Compare
-
- Epitope: AMFWSVPTV
- MHC: HLA-A*02:01
Compare
-
- Epitope: AMFWSVPTV
- MHC: HLA-A*02:01
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.